Direct Answer
Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied mainly in Russian preclinical research on aging, telomerase, and gene expression.
Summary Table
Evidence Level
Preclinical
AI Summary
Epithalon is a synthetic tetrapeptide (AEDG) derived from the pineal peptide preparation epithalamin, studied primarily by Russian research groups. The evidence base is preclinical: laboratory and animal studies describe effects on gene expression, telomerase activity, and tumor development in rodent models. Independent, controlled human outcome trials are lacking, and it is not approved by major regulators. Claims about lifespan extension or anti-aging in humans are not established by the cited literature.
Key Information
Classification
Key Takeaways
- Epithalon is a synthetic tetrapeptide (AEDG) studied mainly in Russian preclinical research
- Reported effects on gene expression and telomerase are from laboratory and animal models
- It is not approved by major regulators, and human anti-aging claims are not established
Scientific Overview
In Plain English
Epithalon is a lab-made four-amino-acid peptide based on an extract from the pineal gland. Most of its study comes from Russian cell and animal research looking at aging-related processes. It has not been approved as a medicine, and human anti-aging claims are not established by high-quality trials.
Scientific Details
Epithalon (Ala-Glu-Asp-Gly) is a synthetic analog of the pineal gland peptide epithalamin. Preclinical studies, largely from Russian groups, describe effects on gene and protein expression during neurogenesis and on the development of spontaneous tumors in transgenic mouse models, and propose telomerase-related mechanisms. The literature is predominantly preclinical, and independent controlled human trials with clinical outcomes are not available.
How It Works
Epithalon is described in research as a short peptide associated with regulation of gene and protein expression, and proposed effects on telomerase activity, in laboratory and animal models. These mechanisms are characterized preclinically and are not confirmed by controlled human studies.
Mechanism of Action
Gene-expression modulation
cell
Cell studies associate the AEDG peptide with changes in gene expression and protein synthesis during neurogenesis.
Proposed telomerase-related activity
cell
Preclinical work has proposed effects on telomerase activity; this is characterized in laboratory models and not confirmed in humans.
Evidence Level
Human Evidence
Independent, controlled human outcome trials are lacking. Much of the human-relevant discussion originates from a small number of Russian research groups and is not widely replicated internationally.
Animal Evidence
Rodent studies describe effects on spontaneous tumor development and age-related measures.
Cell Evidence
In vitro studies describe effects on gene expression and protein synthesis.
Limitations
The literature is predominantly preclinical and concentrated in a small number of research groups; large independent human studies are not available, and anti-aging claims are not established.
Why This Grade
Graded preclinical: evidence is dominated by laboratory and animal studies from a limited set of research groups, without independent controlled human outcome data.
References
- AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism. Molecules.Cell / In Vitrodoi:10.3390/molecules25030609 →
- Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. International Journal of Cancer.Animal Studydoi:10.1002/ijc.10570 →
Alternative Names
- Epitalon
- Epithalone
- AEDG peptide
- Ala-Glu-Asp-Gly
Risks & Safety
- Human safety and efficacy are not established; it is not an approved medicine
- Research-chemical-vendor material is not quality-controlled and may be mislabeled or contaminated
- Long-term effects in humans are uncharacterized
- Anti-aging and longevity claims are not supported by controlled human evidence
Claim Boundaries
ION BLUE is an educational research aggregator. This content summarizes published scientific literature. It is not medically reviewed, is not medical advice, and is not a recommendation to use any substance. Several peptides discussed are research chemicals or investigational drugs not approved for general human use. Consult a licensed healthcare provider. This entry does not assert that Epithalon is safe or effective in humans and is not a recommendation to obtain or use it.
This page summarizes published research and is for informational purposes only; it is not medical advice.